Skeletal muscle senescence and regeneration

Active Grant Awarded

Award ID
FAG101788UPRRG7
Recipient
Awarding agency
Obligated
$50,114

Award facts

Assistance listing
93.AG4 National Institute on Aging Training Individual Projects
Completion date 0% complete
Place of performance
Rochester, MN 55905, USA

Award details come from USAspending.gov.

Description

Abstract
Aging is associated with a progressive decline in skeletal muscle (SKM) mass, function, and regenerative capacity. While our lab has characterized senescent cell populations in SKM of aged mice and humans, their impact on SKM health remains incompletely understood. The goal of this project is to investigate how senescent myofibers, induced by overexpression of P21, influence SKM regeneration and intercellular communication through the production of a distinct, pro-inflammatory senescence-associated secretory phenotype (SASP). The outlined aims will interrogate if P21HIGH myofibers alter the molecular phenotype of cell populations critical to SKM regeneration and, through established measures, compromise the temporal dynamics and quality of SKM regeneration. Specific aim 1 of my research seeks to decipher how P21HIGH myofibers impact SKM regeneration in vivo using our established mouse model of myofiber-specific P21 overexpression. By analyzing regenerative outcomes following muscle injury, I will assess how the presence of senescent myofibers alters key processes such as stem cell function, inflammatory signaling, and extracellular matrix remodeling. Understanding the specific role of P21HIGH myofibers in regeneration will provide critical insights into how aging disrupts tissue repair, thereby paving the way for therapies that improve tissue longevity and prevent age-related decline. Specific aim 2 will investigate how the secretome of P21HIGH myofibers influences SKM cell populations that regulate regeneration, including satellite cells, fibro-adipogenic progenitors, and macrophages. Senescent cells within aged tissues exert deleterious effects through their SASP, which can promote chronic inflammation, fibrosis, and stem cell dysfunction. By analyzing conditioned media from P21-overexpressing myotubes and assessing cellular responses, I aim to identify secreted factors that hinder regenerative processes. This work will elucidate how senescent myofibers disrupt the tissue microenvironment and may provide mechanistic insight into how dysregulated cell-cell communication leads to incomplete or inefficient regenerative responses. This research has translational implications, as findings may inform approaches to neutralize the harmful effects of senescent cells to restore regenerative capacity in aging tissues. The goals of the proposed training plan are to (1) gain multidisciplinary training in aging biology, cellular senescence, and regenerative sciences and (2) develop the technical, professional, and leadership skills for a productive career in biomedical research. I have assembled a strong mentorship team with exceptional expertise in these disciplines and will take advantage of the extraordinary research environments offered at mayo clinic and mayo clinic's robert and arlene kogod center on aging. This F31 fellowship will advance me toward my long-term goal of leading a research program aimed at developing novel regenerative strategies that improve tissue repair and functional recovery in aging populations.

Quick answers

Who received award FAG101788UPRRG7?

FAG101788UPRRG7 was awarded to Mayo Clinic by National Institute on Aging (National Institutes of Health) on November 19, 2026.

How much is award FAG101788UPRRG7 worth?

$50,114 has been obligated on FAG101788UPRRG7.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award